Ira Goldfine,John Kerner,Betty A. Maddux,Michael Campbell,Jack F. Youngren,Peter Kushner
申请号：
US11552686
公开号：
US08143226B2
申请日:
2006.10.25
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors which may be nordihydroguaiarectic acid (NDGA) and doxorubicin.
